Literature DB >> 19721193

Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells.

Andres J Calderon1, Vladimir Muzykantov, Silvia Muro, David M Eckmann.   

Abstract

Vascular drug delivery by administration of carriers targeted to endothelial surface determinants, such as intercellular adhesion molecule (ICAM-1), holds considerable promise to improve disease treatment. As a model to define elusive factors controlling the interplay between carrier motion in the bloodstream and its interactions with molecular targets in the endothelial wall, we used 1 mum beads coated with ICAM-1 monoclonal antibody (Ab) at 370, 1100 or 4100 Ab/microm2. Carriers were perfused at two shear rates over resting or activated endothelial cells, expressing minimum vs. maximum ICAM-1 levels, to determine carrier rolling, binding and detachment. Even at 0.1 Pa and 4100 Ab/microm2, carriers attached only to activated cells (21 fold increase over resting cells), ideal for specific drug targeting to sites of pathology. Binding was increased by raising the Ab surface density on the carrier, e.g., 59.4+/-11.1% increase for carriers having 4100 vs. 1100 Ab/microm2, as a consequence of decreased rolling velocity. Carrier binding was stable even under a high shear stress: carriers with 1100 and 4100 Ab/microm2 withstand shear stress over 3 Pa without detaching from the cells. This is further supported by theoretical modeling. These results will guide vascular targeting of drug carriers via rational design of experimentally tunable parameters.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19721193      PMCID: PMC2766098          DOI: 10.3233/BIR-2009-0544

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  57 in total

1.  Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis.

Authors:  Silvia Muro; Edward H Schuchman; Vladimir R Muzykantov
Journal:  Mol Ther       Date:  2005-09-08       Impact factor: 11.454

2.  Neutrophil traction stresses are concentrated in the uropod during migration.

Authors:  Lee A Smith; Helim Aranda-Espinoza; Jered B Haun; Micah Dembo; Daniel A Hammer
Journal:  Biophys J       Date:  2007-01-11       Impact factor: 4.033

3.  Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung.

Authors:  Phil Oh; Per Borgström; Halina Witkiewicz; Yan Li; Bengt J Borgström; Adrian Chrastina; Koji Iwata; Kurt R Zinn; Richard Baldwin; Jacqueline E Testa; Jan E Schnitzer
Journal:  Nat Biotechnol       Date:  2007-03-04       Impact factor: 54.908

4.  Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression.

Authors:  Eleni Tzima; Miguel Angel Del Pozo; William B Kiosses; Samih A Mohamed; Song Li; Shu Chien; Martin Alexander Schwartz
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

5.  Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells--a potential tool for specific drug delivery.

Authors:  Manuela Voinea; Ileana Manduteanu; Elena Dragomir; Monica Capraru; Maya Simionescu
Journal:  Pharm Res       Date:  2005-08-13       Impact factor: 4.200

6.  Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1.

Authors:  Silvia Muro; Thomas Dziubla; Weining Qiu; John Leferovich; Xiumin Cui; Erik Berk; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2006-02-27       Impact factor: 4.030

7.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).

Authors:  S D Marlin; T A Springer
Journal:  Cell       Date:  1987-12-04       Impact factor: 41.582

8.  Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1.

Authors:  M S Mulligan; A A Vaporciyan; M Miyasaka; T Tamatani; P A Ward
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

9.  Flow-related responses of intracellular inositol phosphate levels in cultured aortic endothelial cells.

Authors:  A R Prasad; S A Logan; R M Nerem; C J Schwartz; E A Sprague
Journal:  Circ Res       Date:  1993-04       Impact factor: 17.367

10.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells.

Authors:  F S Villanueva; R J Jankowski; S Klibanov; M L Pina; S M Alber; S C Watkins; G H Brandenburger; W R Wagner
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

View more
  39 in total

1.  Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1.

Authors:  Tridib Bhowmick; Erik Berk; Xiumin Cui; Vladimir R Muzykantov; Silvia Muro
Journal:  J Control Release       Date:  2011-09-16       Impact factor: 9.776

Review 2.  Nanocarriers for vascular delivery of anti-inflammatory agents.

Authors:  Melissa D Howard; Elizabeth D Hood; Blaine Zern; Vladimir V Shuvaev; Tilo Grosser; Vladimir R Muzykantov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 3.  Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation.

Authors:  Portonovo S Ayyaswamy; Vladimir Muzykantov; David M Eckmann; Ravi Radhakrishnan
Journal:  J Nanotechnol Eng Med       Date:  2013-07-11

Review 4.  Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis.

Authors:  Khosrow Khodabandehlou; Jacqueline J Masehi-Lano; Christopher Poon; Jonathan Wang; Eun Ji Chung
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

5.  Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers.

Authors:  Andres J Calderon; Tridib Bhowmick; John Leferovich; Bharat Burman; Benjamin Pichette; Vladimir Muzykantov; David M Eckmann; Silvia Muro
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

6.  Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.

Authors:  Ann-Marie Chacko; Jingyan Han; Colin F Greineder; Blaine J Zern; John L Mikitsh; Madhura Nayak; Divya Menon; Ian H Johnston; Mortimer Poncz; David M Eckmann; Peter F Davies; Vladimir R Muzykantov
Journal:  ACS Nano       Date:  2015-07-13       Impact factor: 15.881

7.  Nanoparticle Brownian motion and hydrodynamic interactions in the presence of flow fields.

Authors:  B Uma; T N Swaminathan; R Radhakrishnan; D M Eckmann; P S Ayyaswamy
Journal:  Phys Fluids (1994)       Date:  2011-07-26       Impact factor: 3.521

8.  Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery.

Authors:  Jeff Rappaport; Rachel L Manthe; Carmen Garnacho; Silvia Muro
Journal:  Mol Pharm       Date:  2015-04-23       Impact factor: 4.939

9.  Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.

Authors:  Blaine J Zern; Ann-Marie Chacko; Jin Liu; Colin F Greineder; Eric R Blankemeyer; Ravi Radhakrishnan; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2013-02-08       Impact factor: 15.881

Review 10.  Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.

Authors:  William J Kelley; Hanieh Safari; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.